Today: 3 July 2026
Browse Category

Stock Market 8 January 2026

Synopsys stock rises after CES automotive push as AI trade returns to tech

Synopsys stock rises after CES automotive push as AI trade returns to tech

New York, January 7, 2026, 19:36 — After-hours Synopsys, Inc. shares rose in after-hours trading on Wednesday, tracking a renewed bid for AI-linked technology names and fresh attention on the chip-design software maker’s automotive pitch at CES. Synopsys was up 2.2% at $519.70, after trading between $506.13 and $521.43 during the session; rival Cadence Design Systems gained 1.8%.
8 January 2026
·····
Nike stock drops after-hours after sale of NFT unit RTFKT, RBC trims target

Nike stock drops after-hours after sale of NFT unit RTFKT, RBC trims target

New York, Jan 7, 2026, 7:43 PM EST — After-hours Nike shares fell on Wednesday after the company sold RTFKT, its digital products subsidiary, retreating further from blockchain-based collectibles known as NFTs, or non-fungible tokens. A Nike spokesperson said RTFKT “transitioned to a new owner on December 17,” and Nike declined to disclose terms or the buyer. Bloomberg Law
8 January 2026
·
Salad and Go is quitting Texas and Oklahoma — and closing its last 32 stores

Salad and Go is quitting Texas and Oklahoma — and closing its last 32 stores

Salad and Go said on Wednesday it will close all remaining restaurants in Texas and Oklahoma, pulling the drive-thru salad chain out of two states that had become its main growth markets outside Arizona. The move lands as the company tries to reset after a rapid buildout and then a first wave of closures announced in September. It is now shrinking back to a smaller footprint it says it can run better, with fewer moving parts and less distance between its kitchens and stores.
8 January 2026
Compass (COMP) stock jumps after-hours on Q4 outlook lift and $750 mln notes plan ahead of Anywhere merger

Compass (COMP) stock jumps after-hours on Q4 outlook lift and $750 mln notes plan ahead of Anywhere merger

NEW YORK, Jan 7, 2026, 19:26 ET — After-hours Compass, Inc. shares rose 9.4% to $11.84 in after-hours trading on Wednesday after the real estate brokerage flagged stronger fourth-quarter performance and detailed financing plans tied to its pending merger with Anywhere Real Estate. The stock swung between $9.90 and $12.58 during the session on volume of about 103 million shares.
8 January 2026
···
Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

New York, Jan 7, 2026, 18:52 EST — After-hours Merck & Co shares edged down in after-hours trading on Wednesday after U.S. health officials updated the childhood immunization schedule and moved to a single dose for the human papillomavirus vaccine, a change that could pressure demand for Merck’s Gardasil shot. The stock was down about 0.2% at $108.60, after trading between $107.99 and $111.42 in the regular session. HHS.gov
8 January 2026
····
First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

New York, January 7, 2026, 18:48 — After-hours Shares of First Solar fell 10.3% to $241.11 on Wednesday after Jefferies downgraded the U.S. solar panel maker to “hold” from “buy” and cut its price target to $260 from $269. The brokerage cited “limited booking visibility” for 2026 and said a hoped-for “S232” tailwind — shorthand for potential Section 232 duties that can be imposed after a Commerce Department national-security investigation — could “underwhelm investor expectations,” flagging possible carve-outs for Germany and developers moving ahead of any levies. The stock opened at $254.02 and touched $239.26 at its low; volume was about 6.2 million shares. TipRanks
8 January 2026
·······
AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

New York, Jan 7, 2026, 18:35 EST — After-hours AbbVie shares were down about 1% at $231.11 in after-hours trading on Wednesday after the drugmaker denied a Wall Street Journal report that it was in advanced talks to buy cancer-drug developer Revolution Medicines, saying it “is not in discussions with Revolution Medicines.” The stock had closed up 4.2% at $233.42, while Revolution shares slid 11.5% late after jumping nearly 30% earlier, with the report pointing to a valuation around $20 billion. AbbVie has spent more than $20 billion on acquisitions since 2023 as its former blockbuster Humira lost patent protection. Reuters+1
8 January 2026
····
Roblox stock slides after outage, TD Cowen target cut as CES ad push ramps up

Roblox stock slides after outage, TD Cowen target cut as CES ad push ramps up

Roblox shares fell 6.4% on Tuesday, lagging a broader market rise, after an overnight outage and a price-target cut from TD Cowen put fresh focus on the platform’s growth. The stock ended at $75.83. https://www.nasdaq.com/articles/roblox-rblx-stock-drops-despite-market-gains-important-facts-note-0 The move extends a pullback of about 17% over the past month and lands just as investors position for Roblox’s next earnings update. A key question is whether new ad products can keep revenue momentum if engagement cools after a year shaped by viral hits.
8 January 2026
·
1 … 856 857 858 859 860 … 1,616

Stock Market Today

  • AMD Trades at 54.08 Forward P/E, Well Above Sector and Peers as Growth Picture Stays Mixed
    July 3, 2026, 3:17 PM EDT. Advanced Micro Devices (AMD) is trading at a 12-month forward price-to-earnings ratio of 54.08, much higher than the Zacks Computer & Technology sector's 23.18 average, with rivals NVIDIA at 18.9 and Broadcom at 21.57. Shares have jumped 142.2% so far this year, beating out the sector's 14.6% rise but still trailing Intel's 226.6% rally. Growth gets a lift from strong demand for data center chips, but the company faces weaker gaming sales, supply limits, and tough competition from NVIDIA and Intel. Consensus earnings for 2026 hold steady at $7.18 a share, which would be up 72.2% from 2025. Margins could take a hit as AI accelerators-typically lower margin-make up more of the product mix. With competition rising and mixed signals across business lines, investors may debate whether AMD's valuation premium can last.
Go toTop